Progyny, Inc. Announces Details for Its Second Quarter 2022 Results Report
Progyny (PGNY) will release its financial results for Q2 2022 on August 4, 2022, after market close. An investor conference call is scheduled for 4:45 PM ET. Participants in the U.S. can join by dialing 1-866-825-7331, with international access via 1-973-413-6106, using passcode 265484. A replay will be available until August 11, 2022. Progyny, recognized for its comprehensive fertility benefits, aims to provide optimal clinical outcomes and reduce healthcare costs.
- Scheduled financial results report for Q2 2022 on August 4, 2022.
- Conference call indicates transparency and engagement with investors.
- None.
NEW YORK, July 21, 2022 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, will report its financial results for the quarterly period ended June 30, 2022 after the close of the market on Thursday, August 4, 2022.
The company will host a conference call at 4:45 P.M. Eastern Time (1:45 P.M. Pacific Time) and issue a press release regarding its financial results prior to the start of the call.
Interested participants in the United States may access the conference call by dialing 1.866.825.7331 and using the passcode 265484. International participants may access the call by dialing 1.973.413.6106 and using the same passcode.
An audio replay of the call will be available through Thursday, August 11, 2022 and may be accessed by dialing 1.800.332.6854 (U.S. participants) or 1.973.528.0005 (international participants) with the passcode 265484.
A live webcast and archive of the call will be available from the Events and Presentations section of the Company’s website at http://investors.progyny.com.
About Progyny
Progyny (Nasdaq: PGNY) is a leading fertility benefits management company. We are redefining fertility and family building benefits, proving that a comprehensive and inclusive solution can simultaneously benefit employers, patients, and physicians.
Our benefits solution empowers patients with education and guidance from a dedicated Patient Care Advocate (PCA), provides access to a premier network of fertility specialists using the latest science and technologies, reduces healthcare costs for the nation’s leading employers, and drives optimal clinical outcomes. We envision a world where anyone who wants to have a child can do so.
Headquartered in New York City, Progyny has been recognized for its leadership and growth by CNBC Disruptor 50, Modern Healthcare’s Best Places to Work in Healthcare, Financial Times, INC. 5000, and Crain’s Fast 50 for NYC. For more information, visit www.progyny.com.
For Further Information, Please Contact:
Investors:
James Hart
investors@progyny.com
Media:
Selena Yang
media@progyny.com
FAQ
When will Progyny report its Q2 2022 financial results?
What time is the Progyny investor conference call?
How can I access the audio replay of Progyny's conference call?
What is the passcode for Progyny's conference call?
